Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-14-008069
Filing Date
2014-02-24
Accepted
2014-02-24 19:59:10
Documents
1
Period of Report
2014-02-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6009
  Complete submission text file 0001127602-14-008069.txt   7321
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Issuer) CIK: 0000850693 (see all company filings)

EIN.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALLERGAN, INC. 2525 DUPONT DRIVE IRVINE CA 92612
Business Address
LAVIGNE LOUIS J JR (Reporting) CIK: 0001214127 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-10269 | Film No.: 14638523